With a clean-catch urine collection, the test Prosta~Seq provides all the information needed to accurately diagnose culture-negative infections in patients with prostatitis. This novel test also provides actionable data on bacterial load data and drug resistance genes. Prosta~Seq uses the latest molecular biological methods to provide an understandable but comprehensive report for the most difficult patients who are culture-negative for prostatitis . For the right patient, this may be the perfect test to aid in the treatment for prostatitis.
Accurately diagnose culture negative infections in urine. Using the Urine microbiome, the Prosta-Seq assay can identify every bacteria, parasite and targeted viruses. With the Prosta~Seq assay, the physician is provided with a drug resistance report that may include but not limited to triazole, macrolide, lincosamide, beta lactam, tetracycline, aminoglycoside, gentamicin, tobramycin and 5-nitroimidazole.